Capricor Therapeutics, Inc. (CAPR)
NASDAQ: CAPR · Real-Time Price · USD
9.48
-0.02 (-0.16%)
At close: Apr 1, 2025, 4:00 PM
9.79
+0.31 (3.32%)
After-hours: Apr 1, 2025, 7:54 PM EDT

Capricor Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
433627151957170
Upgrade
Market Cap Growth
316.72%316.72%57.92%34.76%0.89%1046.92%
Upgrade
Enterprise Value
283544124493035
Upgrade
Last Close Price
9.4713.804.893.862.933.43
Upgrade
PS Ratio
14.9828.185.9837.37288.92226.06
Upgrade
PB Ratio
2.974.316.668.092.262.49
Upgrade
P/TBV Ratio
4.314.316.668.092.262.49
Upgrade
P/FCF Ratio
--61.25--
Upgrade
P/OCF Ratio
--19.39--
Upgrade
EV/Sales Ratio
12.6924.434.9419.10122.30113.31
Upgrade
EV/FCF Ratio
--31.31--
Upgrade
Debt / Equity Ratio
0.010.010.100.220.090.01
Upgrade
Debt / FCF Ratio
---1.64--
Upgrade
Asset Turnover
0.190.190.460.060.010.01
Upgrade
Quick Ratio
7.707.701.591.788.5411.01
Upgrade
Current Ratio
7.777.771.631.828.8211.33
Upgrade
Return on Equity (ROE)
-48.16%-48.16%-129.63%-134.49%-67.23%-77.95%
Upgrade
Return on Assets (ROA)
-23.21%-23.21%-27.66%-40.60%-34.46%-37.42%
Upgrade
Return on Capital (ROIC)
-30.98%-30.98%-76.81%-76.41%-41.71%-48.40%
Upgrade
Earnings Yield
-9.35%-6.45%-14.80%-30.43%-28.30%-19.47%
Upgrade
FCF Yield
-9.60%-6.62%-18.36%1.63%-25.45%-15.12%
Upgrade
Buyback Yield / Dilution
-31.52%-31.52%-9.06%-6.34%-48.28%-319.55%
Upgrade
Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q